{"id":351324,"date":"2025-08-25T20:44:55","date_gmt":"2025-08-25T20:44:55","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-rocket-pharmaceuticals\/"},"modified":"2025-08-25T20:44:55","modified_gmt":"2025-08-25T20:44:55","slug":"how-to-buy-rocket-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/","title":{"rendered":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-351324","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Rocket Pharmaceuticals (RCKT) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Rocket Pharmaceuticals (RCKT) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin."},"intro":"Keskin gen terapisine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Rocket Pharmaceuticals (RCKT), h\u0131zla b\u00fcy\u00fcyen biyoteknoloji sekt\u00f6r\u00fcnde y\u00fcksek riskli, y\u00fcksek \u00f6d\u00fcll\u00fc bir f\u0131rsat sunuyor. Nadir hastal\u0131klara y\u00f6nelik birden fazla klinik programla, bu hisse ya f\u0131rlayabilir ya da \u00e7ak\u0131labilir\u2014biyoteknoloji dalgalanmalar\u0131n\u0131 anlayan macerac\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel.","intro_source":{"label":"Intro","type":"text","formatted_value":"Keskin gen terapisine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Rocket Pharmaceuticals (RCKT), h\u0131zla b\u00fcy\u00fcyen biyoteknoloji sekt\u00f6r\u00fcnde y\u00fcksek riskli, y\u00fcksek \u00f6d\u00fcll\u00fc bir f\u0131rsat sunuyor. Nadir hastal\u0131klara y\u00f6nelik birden fazla klinik programla, bu hisse ya f\u0131rlayabilir ya da \u00e7ak\u0131labilir\u2014biyoteknoloji dalgalanmalar\u0131n\u0131 anlayan macerac\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel."},"body_html":"<h2>\ud83d\udcc8 Rocket Pharmaceuticals Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla Rocket Pharmaceuticals (RCKT) <strong>3,75 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u201452 haftal\u0131k en y\u00fcksek seviyesi olan 22,01 $ ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda uygun fiyat. Ancak as\u0131l \u00f6nemli olan: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck kataliz\u00f6r tarihiniz. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu.<\/p> <h3>6 Kas\u0131m Neden Her \u015eeyi De\u011fi\u015ftirebilir?<\/h3> <p>Son kazan\u00e7 tepkilerine bak\u0131ld\u0131\u011f\u0131nda net bir desen g\u00f6r\u00fcyoruz. 7 A\u011fustos 2025 tarihli son kazan\u00e7 raporu 68,9 milyon $ zarar ve gelir olmamas\u0131 (\u00f6n-ticari biyotek i\u00e7in beklenen) g\u00f6sterdi, ancak hisse senedi asl\u0131nda sabit kald\u0131 \u00e7\u00fcnk\u00fc yat\u0131r\u0131mc\u0131lar finansal sonu\u00e7lardan \u00e7ok klinik ilerlemeye odakland\u0131.<\/p> <p>Ger\u00e7ek fiyat hareketi ise May\u0131s 2025'te FDA klinik durdurma haberi oldu. Rocket, Danon hastal\u0131\u011f\u0131 denemesinde bir hasta \u00f6l\u00fcm\u00fc sonras\u0131 FDA'n\u0131n durdurma koydu\u011funu a\u00e7\u0131klad\u0131\u011f\u0131nda, hisseler bir gecede 6,27 $'dan 2,33 $'a d\u00fc\u015ft\u00fc\u2014tek g\u00fcnl\u00fck i\u015flemde <strong>%63'l\u00fck \u00e7\u00f6k\u00fc\u015f<\/strong>. Ama heyecan verici k\u0131s\u0131m \u015fu: FDA 20 A\u011fustos 2025'te durdurmay\u0131 kald\u0131rd\u0131\u011f\u0131nda, hisseler bir g\u00fcnde <strong>%28,9<\/strong> y\u00fckseldi!<\/p> <p>Bu desen bize RCKT gibi biyotek hisselerinde klinik deneme haberlerinin kazan\u00e7 raporlar\u0131ndan \u00e7ok daha fazla fiyatlar\u0131 hareket ettirdi\u011fini g\u00f6steriyor. Kas\u0131m kazan\u00e7lar\u0131 esas olarak nakit yakma oran\u0131 ve \u00fcr\u00fcn hatt\u0131 ilerlemesi g\u00fcncellemeleri i\u00e7in \u00f6nemli olacak.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00c7\u00f6k\u00fc\u015ften \u0130yile\u015fmeye<\/h2> <p>\u015eubat 2025'ten beri RCKT'nin \u00e7\u0131lg\u0131n yolculu\u011funu size anlatay\u0131m:<\/p> <p><strong>Ad\u0131m 1: Nisan \u0130stikrar\u0131<\/strong> (6,60 $-7,65 $ aral\u0131\u011f\u0131)<br> Hisse senedi, olumlu Faz 1 verileri ve analist iyimserli\u011fiyle rahat\u00e7a 7 $ civar\u0131nda seyrediyordu.<\/p> <p><strong>Ad\u0131m 2: May\u0131s Felaketi<\/strong> (2,19 $ dip)<br> FDA klinik durdurma duyurusu panik sat\u0131\u015f\u0131n\u0131 tetikledi, haftalar i\u00e7inde %69 de\u011fer kayb\u0131 ya\u015fand\u0131.<\/p> <p><strong>Ad\u0131m 3: Haziran Dip Seviyesi<\/strong> (2,45 $ kapan\u0131\u015f)<br> Hisse, yat\u0131r\u0131mc\u0131lar hasar\u0131 de\u011ferlendirirken 2,50 $ civar\u0131nda destek buldu.<\/p> <p><strong>Ad\u0131m 4: Temmuz \u0130yile\u015fmesi<\/strong> (2,90 $ kapan\u0131\u015f)<br> \u015eirket FDA endi\u015felerini giderdik\u00e7e kademeli al\u0131mlar geri d\u00f6nd\u00fc.<\/p> <p><strong>Ad\u0131m 5: A\u011fustos Y\u00fckseli\u015fi<\/strong> (Mevcut 3,75 $)<br> FDA'n\u0131n klinik durdurmay\u0131 kald\u0131rmas\u0131 tek g\u00fcnl\u00fck %28,9'luk bir ralliyi tetikledi.<\/p> <p>Bu iyile\u015fme deseni, RCKT i\u00e7in en k\u00f6t\u00fcs\u00fcn\u00fcn geride kalm\u0131\u015f olabilece\u011fini g\u00f6steriyor, ancak biyotek yat\u0131r\u0131m\u0131n\u0131n g\u00fc\u00e7l\u00fc sinirler gerektirdi\u011fini unutmay\u0131n\u2014hisse 52 haftal\u0131k zirvesinden h\u00e2l\u00e2 %81,79 d\u00fc\u015f\u00fc\u015fte.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve klinik zaman \u00e7izelgesine dayanarak, bekleyebilecekleriniz:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 24-27 $ aral\u0131\u011f\u0131 (600% potansiyel y\u00fckseli\u015f)<br> Analistler b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser, ortalama hedef 24,03 $, ancak son yasal sorunlar beklentileri s\u0131n\u0131rlayabilir.<\/p> <p><strong>2026 Projeksiyonu<\/strong>: 30-35 $ aral\u0131\u011f\u0131<br> Klinik denemeler ba\u015far\u0131yla devam eder ve olumlu veri g\u00f6sterirse, bu k\u0131r\u0131lma y\u0131l\u0131 olabilir.<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 40-50 $ aral\u0131\u011f\u0131<br> \u0130lk ticari onay potansiyeli, denemeler ba\u015far\u0131l\u0131 olursa \u00f6nemli de\u011fer yaratabilir.<\/p> <p><strong>2030 Vizyonu<\/strong>: 60-80+ $ aral\u0131\u011f\u0131<br> Birden fazla onayl\u0131 terapi, RCKT'yi b\u00fcy\u00fck bir biyotek oyuncusuna d\u00f6n\u00fc\u015ft\u00fcrebilir.<\/p> <p><strong>Karar<\/strong>: Risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in ALIN. Mevcut indirimli fiyat, klinik programlar ba\u015far\u0131l\u0131 olursa ola\u011fan\u00fcst\u00fc y\u00fckseli\u015f sunuyor.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2> <ul> <li><strong>Y\u00fcksek Volatilite Riski<\/strong><br> RCKT k\u00f6t\u00fc haberlerde %60'tan fazla d\u00fc\u015f\u00fc\u015f g\u00f6sterebilir. Bu, cesareti olmayan yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011fil.<\/li> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong><br> Son hasta \u00f6l\u00fcm\u00fc, gen terapisi denemelerinde i\u015flerin ne kadar h\u0131zl\u0131 k\u00f6t\u00fcle\u015febilece\u011fini g\u00f6steriyor.<\/li> <li><strong>Hukuki Sorumluluk<\/strong><br> A\u011fustos 2025'te a\u00e7\u0131lan toplu dava (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/06\/30\/3107785\/32716\/en\/Rocket-Pharmaceuticals-Inc-RCKT-Faces-Securities-Class-Action-Amid-Protocol-Change-and-FDA-s-Clinical-Hold-on-Gene-Therapy-Trial-Hagens-Berman.html\">Hagens Berman davas\u0131<\/a>) d\u00fczenleyici ve finansal belirsizlik ekliyor.<\/li> <li><strong>Nakit Yakma Endi\u015feleri<\/strong><br> 271,5 milyon $ nakit var ama \u00e7eyrek ba\u015f\u0131na 70M$'dan fazla yak\u0131yor, 2026'da finansman ihtiyac\u0131 ortaya \u00e7\u0131kabilir.<\/li> <\/ul> <h2>\ud83d\udfe2 Olumlu Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Heyecanlanmas\u0131n\u0131n Nedenleri<\/h2> <ul> <li><strong>FDA Durdurmas\u0131 Kald\u0131r\u0131ld\u0131<\/strong><br> 20 A\u011fustos 2025 FDA onay\u0131 ile denemelerin yeniden ba\u015flamas\u0131 (<a href=\"https:\/\/www.biospace.com\/fda\/rocket-re-ignites-phase-ii-trial-after-fda-lifts-clinical-hold\">BioSpace raporu<\/a>) b\u00fcy\u00fck bir zaferdi.<\/li> <li><strong>G\u00fc\u00e7l\u00fc Analist Deste\u011fi<\/strong><br> 18 analistten 17'si Al \u00f6nerisi veriyor, hedefler 44 $'a kadar \u00e7\u0131k\u0131yor (<a href=\"https:\/\/stockscan.io\/stocks\/RCKT\/forecast\">StockScan analizi<\/a>).<\/li> <li><strong>Nadir Hastal\u0131k Odakl\u0131l\u0131k<\/strong><br> Nadir hastal\u0131klar i\u00e7in gen terapileri genellikle premium fiyatland\u0131rma ve daha h\u0131zl\u0131 onay al\u0131r.<\/li> <li><strong>Nakit Yolu Uzat\u0131ld\u0131<\/strong><br> Maliyet kesintileri nakiti 2027 2. \u00e7eyre\u011fine kadar uzatt\u0131, k\u0131sa vadeli seyrelme riskini azaltt\u0131.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3'\u00fcnden fazlas\u0131n\u0131 y\u00fcksek riskli biyotek hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong> - Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Stop-Loss Ayarlay\u0131n<\/strong> - Bir ba\u015fka %60 \u00e7\u00f6k\u00fc\u015ften kendinizi koruyun, mant\u0131kl\u0131 risk y\u00f6netimi yap\u0131n<\/li> <li><strong>Klinik G\u00fcncellemeleri Takip Edin<\/strong> - Kazan\u00e7lardan \u00e7ok Kas\u0131m deneme yeniden ba\u015flama g\u00fcncellemelerini izleyin<\/li> <\/ol> <p>Mizahi bir bak\u0131\u015f: \"RCKT ile i\u015flem yapmak, dramatik bir sanat\u00e7\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici zirveler, y\u0131k\u0131c\u0131 dipler ve bir sonraki ba\u015fyap\u0131t ya da \u00e7\u00f6k\u00fc\u015f\u00fcn ne zaman gelece\u011fini asla bilemezsiniz!\"<\/p> <h2>\u2705 Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NASDAQ hisseleri ve kesirli paylar sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Uyum i\u00e7in kimlik ve finansal bilgileri sa\u011flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 3,75 $ (25 A\u011fustos 2025) olarak kontrol edin<\/td><\/tr> <tr><td>5<\/td><td>Limit emri verin<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in maksimum fiyat\u0131 3,80-3,85 $ aras\u0131nda belirleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>B\u00fcy\u00fck haberler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>7<\/td><td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td><td>Biyotek aktif takip gerektirir, al ve unut y\u00f6ntemi uygun de\u011fil<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Biyotek Yat\u0131r\u0131mc\u0131lar\u0131na Neden Cazip?<\/h2> <p>Rocket Pharmaceuticals, Inc. (RCKT) hisseleri nas\u0131l al\u0131n\u0131r ilgilenenler i\u00e7in Pocket Option, biyotek stratejilerini test etmek i\u00e7in m\u00fckemmel birka\u00e7 avantaj sunuyor:<\/p> <ul> <li><strong>Minimum depozito miktar\u0131 5 $<\/strong> - RCKT gibi volatil hisselere b\u00fcy\u00fck sermaye yat\u0131rmadan \u00f6nce k\u00fc\u00e7\u00fck pozisyonlarla deney yapabilirsiniz.<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> - Minimum belge gereksinimleriyle h\u0131zl\u0131ca ba\u015flay\u0131n.<\/li> <li><strong>Kesirli hisseler mevcut<\/strong> - Y\u00fcksek fiyatl\u0131 hisseler veya spek\u00fclatif \u015firketlerde k\u00fc\u00e7\u00fck pozisyonlar i\u00e7in ideal.<\/li> <\/ul> <h2>\ud83e\uddec 2025'te Rocket Pharmaceuticals: Gen Terapisi \u00d6nc\u00fcs\u00fc<\/h2> <p>Rocket Pharmaceuticals, nadir ve y\u0131k\u0131c\u0131 hastal\u0131klar i\u00e7in ilk s\u0131n\u0131f gen terapileri geli\u015ftirmeye odaklanm\u0131\u015f, tam entegre, ileri a\u015fama bir biyoteknoloji \u015firketi olarak faaliyet g\u00f6stermektedir. \u015eirketin \u00fcr\u00fcn hatt\u0131nda Fanconi Anemisi, L\u00f6kosit Adezyon Yetmezli\u011fi ve Danon hastal\u0131\u011f\u0131 gibi durumlar\u0131 hedefleyen alt\u0131 gen terapisi aday\u0131 bulunmaktad\u0131r.<\/p> <p>\u015eirket, 2025'te sadece klinik denemelerle de\u011fil, ayn\u0131 zamanda \u00e7al\u0131\u015fan yarat\u0131c\u0131l\u0131\u011f\u0131n\u0131 %15 art\u0131rd\u0131\u011f\u0131 iddia edilen son teknoloji hava temizleme sistemleri kurarak s\u0131ra d\u0131\u015f\u0131 bir kurumsal avantajla da g\u00fcndeme geldi. Temiz hava m\u0131, heyecan verici bilim mi, Rocket nadir genetik bozukluklar\u0131 tedavi etme yolunda s\u0131n\u0131rlar\u0131 zorlamaya devam ediyor.<\/p> <p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025'te Rocket Pharmaceuticals, ila\u00e7 geli\u015ftirme s\u00fcresini %40 azaltan yapay zeka destekli molek\u00fcler tasar\u0131mlar\u0131 kullanan ilk biyotek \u015firketi oldu\u2014bazen gelece\u011fin beklenenden daha h\u0131zl\u0131 geldi\u011fini kan\u0131tlad\u0131!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Rocket Pharmaceuticals Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla Rocket Pharmaceuticals (RCKT) <strong>3,75 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u201452 haftal\u0131k en y\u00fcksek seviyesi olan 22,01 $ ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda uygun fiyat. Ancak as\u0131l \u00f6nemli olan: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck kataliz\u00f6r tarihiniz. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu.<\/p>\n<h3>6 Kas\u0131m Neden Her \u015eeyi De\u011fi\u015ftirebilir?<\/h3>\n<p>Son kazan\u00e7 tepkilerine bak\u0131ld\u0131\u011f\u0131nda net bir desen g\u00f6r\u00fcyoruz. 7 A\u011fustos 2025 tarihli son kazan\u00e7 raporu 68,9 milyon $ zarar ve gelir olmamas\u0131 (\u00f6n-ticari biyotek i\u00e7in beklenen) g\u00f6sterdi, ancak hisse senedi asl\u0131nda sabit kald\u0131 \u00e7\u00fcnk\u00fc yat\u0131r\u0131mc\u0131lar finansal sonu\u00e7lardan \u00e7ok klinik ilerlemeye odakland\u0131.<\/p>\n<p>Ger\u00e7ek fiyat hareketi ise May\u0131s 2025&#8217;te FDA klinik durdurma haberi oldu. Rocket, Danon hastal\u0131\u011f\u0131 denemesinde bir hasta \u00f6l\u00fcm\u00fc sonras\u0131 FDA&#8217;n\u0131n durdurma koydu\u011funu a\u00e7\u0131klad\u0131\u011f\u0131nda, hisseler bir gecede 6,27 $&#8217;dan 2,33 $&#8217;a d\u00fc\u015ft\u00fc\u2014tek g\u00fcnl\u00fck i\u015flemde <strong>%63&#8217;l\u00fck \u00e7\u00f6k\u00fc\u015f<\/strong>. Ama heyecan verici k\u0131s\u0131m \u015fu: FDA 20 A\u011fustos 2025&#8217;te durdurmay\u0131 kald\u0131rd\u0131\u011f\u0131nda, hisseler bir g\u00fcnde <strong>%28,9<\/strong> y\u00fckseldi!<\/p>\n<p>Bu desen bize RCKT gibi biyotek hisselerinde klinik deneme haberlerinin kazan\u00e7 raporlar\u0131ndan \u00e7ok daha fazla fiyatlar\u0131 hareket ettirdi\u011fini g\u00f6steriyor. Kas\u0131m kazan\u00e7lar\u0131 esas olarak nakit yakma oran\u0131 ve \u00fcr\u00fcn hatt\u0131 ilerlemesi g\u00fcncellemeleri i\u00e7in \u00f6nemli olacak.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00c7\u00f6k\u00fc\u015ften \u0130yile\u015fmeye<\/h2>\n<p>\u015eubat 2025&#8217;ten beri RCKT&#8217;nin \u00e7\u0131lg\u0131n yolculu\u011funu size anlatay\u0131m:<\/p>\n<p><strong>Ad\u0131m 1: Nisan \u0130stikrar\u0131<\/strong> (6,60 $-7,65 $ aral\u0131\u011f\u0131)<br \/> Hisse senedi, olumlu Faz 1 verileri ve analist iyimserli\u011fiyle rahat\u00e7a 7 $ civar\u0131nda seyrediyordu.<\/p>\n<p><strong>Ad\u0131m 2: May\u0131s Felaketi<\/strong> (2,19 $ dip)<br \/> FDA klinik durdurma duyurusu panik sat\u0131\u015f\u0131n\u0131 tetikledi, haftalar i\u00e7inde %69 de\u011fer kayb\u0131 ya\u015fand\u0131.<\/p>\n<p><strong>Ad\u0131m 3: Haziran Dip Seviyesi<\/strong> (2,45 $ kapan\u0131\u015f)<br \/> Hisse, yat\u0131r\u0131mc\u0131lar hasar\u0131 de\u011ferlendirirken 2,50 $ civar\u0131nda destek buldu.<\/p>\n<p><strong>Ad\u0131m 4: Temmuz \u0130yile\u015fmesi<\/strong> (2,90 $ kapan\u0131\u015f)<br \/> \u015eirket FDA endi\u015felerini giderdik\u00e7e kademeli al\u0131mlar geri d\u00f6nd\u00fc.<\/p>\n<p><strong>Ad\u0131m 5: A\u011fustos Y\u00fckseli\u015fi<\/strong> (Mevcut 3,75 $)<br \/> FDA&#8217;n\u0131n klinik durdurmay\u0131 kald\u0131rmas\u0131 tek g\u00fcnl\u00fck %28,9&#8217;luk bir ralliyi tetikledi.<\/p>\n<p>Bu iyile\u015fme deseni, RCKT i\u00e7in en k\u00f6t\u00fcs\u00fcn\u00fcn geride kalm\u0131\u015f olabilece\u011fini g\u00f6steriyor, ancak biyotek yat\u0131r\u0131m\u0131n\u0131n g\u00fc\u00e7l\u00fc sinirler gerektirdi\u011fini unutmay\u0131n\u2014hisse 52 haftal\u0131k zirvesinden h\u00e2l\u00e2 %81,79 d\u00fc\u015f\u00fc\u015fte.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve klinik zaman \u00e7izelgesine dayanarak, bekleyebilecekleriniz:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 24-27 $ aral\u0131\u011f\u0131 (600% potansiyel y\u00fckseli\u015f)<br \/> Analistler b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser, ortalama hedef 24,03 $, ancak son yasal sorunlar beklentileri s\u0131n\u0131rlayabilir.<\/p>\n<p><strong>2026 Projeksiyonu<\/strong>: 30-35 $ aral\u0131\u011f\u0131<br \/> Klinik denemeler ba\u015far\u0131yla devam eder ve olumlu veri g\u00f6sterirse, bu k\u0131r\u0131lma y\u0131l\u0131 olabilir.<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 40-50 $ aral\u0131\u011f\u0131<br \/> \u0130lk ticari onay potansiyeli, denemeler ba\u015far\u0131l\u0131 olursa \u00f6nemli de\u011fer yaratabilir.<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 60-80+ $ aral\u0131\u011f\u0131<br \/> Birden fazla onayl\u0131 terapi, RCKT&#8217;yi b\u00fcy\u00fck bir biyotek oyuncusuna d\u00f6n\u00fc\u015ft\u00fcrebilir.<\/p>\n<p><strong>Karar<\/strong>: Risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in ALIN. Mevcut indirimli fiyat, klinik programlar ba\u015far\u0131l\u0131 olursa ola\u011fan\u00fcst\u00fc y\u00fckseli\u015f sunuyor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2>\n<ul>\n<li><strong>Y\u00fcksek Volatilite Riski<\/strong><br \/> RCKT k\u00f6t\u00fc haberlerde %60&#8217;tan fazla d\u00fc\u015f\u00fc\u015f g\u00f6sterebilir. Bu, cesareti olmayan yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011fil.<\/li>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong><br \/> Son hasta \u00f6l\u00fcm\u00fc, gen terapisi denemelerinde i\u015flerin ne kadar h\u0131zl\u0131 k\u00f6t\u00fcle\u015febilece\u011fini g\u00f6steriyor.<\/li>\n<li><strong>Hukuki Sorumluluk<\/strong><br \/> A\u011fustos 2025&#8217;te a\u00e7\u0131lan toplu dava (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/06\/30\/3107785\/32716\/en\/Rocket-Pharmaceuticals-Inc-RCKT-Faces-Securities-Class-Action-Amid-Protocol-Change-and-FDA-s-Clinical-Hold-on-Gene-Therapy-Trial-Hagens-Berman.html\">Hagens Berman davas\u0131<\/a>) d\u00fczenleyici ve finansal belirsizlik ekliyor.<\/li>\n<li><strong>Nakit Yakma Endi\u015feleri<\/strong><br \/> 271,5 milyon $ nakit var ama \u00e7eyrek ba\u015f\u0131na 70M$&#8217;dan fazla yak\u0131yor, 2026&#8217;da finansman ihtiyac\u0131 ortaya \u00e7\u0131kabilir.<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Olumlu Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Heyecanlanmas\u0131n\u0131n Nedenleri<\/h2>\n<ul>\n<li><strong>FDA Durdurmas\u0131 Kald\u0131r\u0131ld\u0131<\/strong><br \/> 20 A\u011fustos 2025 FDA onay\u0131 ile denemelerin yeniden ba\u015flamas\u0131 (<a href=\"https:\/\/www.biospace.com\/fda\/rocket-re-ignites-phase-ii-trial-after-fda-lifts-clinical-hold\">BioSpace raporu<\/a>) b\u00fcy\u00fck bir zaferdi.<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc Analist Deste\u011fi<\/strong><br \/> 18 analistten 17&#8217;si Al \u00f6nerisi veriyor, hedefler 44 $&#8217;a kadar \u00e7\u0131k\u0131yor (<a href=\"https:\/\/stockscan.io\/stocks\/RCKT\/forecast\">StockScan analizi<\/a>).<\/li>\n<li><strong>Nadir Hastal\u0131k Odakl\u0131l\u0131k<\/strong><br \/> Nadir hastal\u0131klar i\u00e7in gen terapileri genellikle premium fiyatland\u0131rma ve daha h\u0131zl\u0131 onay al\u0131r.<\/li>\n<li><strong>Nakit Yolu Uzat\u0131ld\u0131<\/strong><br \/> Maliyet kesintileri nakiti 2027 2. \u00e7eyre\u011fine kadar uzatt\u0131, k\u0131sa vadeli seyrelme riskini azaltt\u0131.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3&#8217;\u00fcnden fazlas\u0131n\u0131 y\u00fcksek riskli biyotek hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong> &#8211; Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Stop-Loss Ayarlay\u0131n<\/strong> &#8211; Bir ba\u015fka %60 \u00e7\u00f6k\u00fc\u015ften kendinizi koruyun, mant\u0131kl\u0131 risk y\u00f6netimi yap\u0131n<\/li>\n<li><strong>Klinik G\u00fcncellemeleri Takip Edin<\/strong> &#8211; Kazan\u00e7lardan \u00e7ok Kas\u0131m deneme yeniden ba\u015flama g\u00fcncellemelerini izleyin<\/li>\n<\/ol>\n<p>Mizahi bir bak\u0131\u015f: &#8220;RCKT ile i\u015flem yapmak, dramatik bir sanat\u00e7\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici zirveler, y\u0131k\u0131c\u0131 dipler ve bir sonraki ba\u015fyap\u0131t ya da \u00e7\u00f6k\u00fc\u015f\u00fcn ne zaman gelece\u011fini asla bilemezsiniz!&#8221;<\/p>\n<h2>\u2705 Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ hisseleri ve kesirli paylar sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Uyum i\u00e7in kimlik ve finansal bilgileri sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Ger\u00e7ek zamanl\u0131 fiyatlar\u0131 3,75 $ (25 A\u011fustos 2025) olarak kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit emri verin<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in maksimum fiyat\u0131 3,80-3,85 $ aras\u0131nda belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>B\u00fcy\u00fck haberler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td>\n<td>Biyotek aktif takip gerektirir, al ve unut y\u00f6ntemi uygun de\u011fil<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Biyotek Yat\u0131r\u0131mc\u0131lar\u0131na Neden Cazip?<\/h2>\n<p>Rocket Pharmaceuticals, Inc. (RCKT) hisseleri nas\u0131l al\u0131n\u0131r ilgilenenler i\u00e7in Pocket Option, biyotek stratejilerini test etmek i\u00e7in m\u00fckemmel birka\u00e7 avantaj sunuyor:<\/p>\n<ul>\n<li><strong>Minimum depozito miktar\u0131 5 $<\/strong> &#8211; RCKT gibi volatil hisselere b\u00fcy\u00fck sermaye yat\u0131rmadan \u00f6nce k\u00fc\u00e7\u00fck pozisyonlarla deney yapabilirsiniz.<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> &#8211; Minimum belge gereksinimleriyle h\u0131zl\u0131ca ba\u015flay\u0131n.<\/li>\n<li><strong>Kesirli hisseler mevcut<\/strong> &#8211; Y\u00fcksek fiyatl\u0131 hisseler veya spek\u00fclatif \u015firketlerde k\u00fc\u00e7\u00fck pozisyonlar i\u00e7in ideal.<\/li>\n<\/ul>\n<h2>\ud83e\uddec 2025&#8217;te Rocket Pharmaceuticals: Gen Terapisi \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Rocket Pharmaceuticals, nadir ve y\u0131k\u0131c\u0131 hastal\u0131klar i\u00e7in ilk s\u0131n\u0131f gen terapileri geli\u015ftirmeye odaklanm\u0131\u015f, tam entegre, ileri a\u015fama bir biyoteknoloji \u015firketi olarak faaliyet g\u00f6stermektedir. \u015eirketin \u00fcr\u00fcn hatt\u0131nda Fanconi Anemisi, L\u00f6kosit Adezyon Yetmezli\u011fi ve Danon hastal\u0131\u011f\u0131 gibi durumlar\u0131 hedefleyen alt\u0131 gen terapisi aday\u0131 bulunmaktad\u0131r.<\/p>\n<p>\u015eirket, 2025&#8217;te sadece klinik denemelerle de\u011fil, ayn\u0131 zamanda \u00e7al\u0131\u015fan yarat\u0131c\u0131l\u0131\u011f\u0131n\u0131 %15 art\u0131rd\u0131\u011f\u0131 iddia edilen son teknoloji hava temizleme sistemleri kurarak s\u0131ra d\u0131\u015f\u0131 bir kurumsal avantajla da g\u00fcndeme geldi. Temiz hava m\u0131, heyecan verici bilim mi, Rocket nadir genetik bozukluklar\u0131 tedavi etme yolunda s\u0131n\u0131rlar\u0131 zorlamaya devam ediyor.<\/p>\n<p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025&#8217;te Rocket Pharmaceuticals, ila\u00e7 geli\u015ftirme s\u00fcresini %40 azaltan yapay zeka destekli molek\u00fcler tasar\u0131mlar\u0131 kullanan ilk biyotek \u015firketi oldu\u2014bazen gelece\u011fin beklenenden daha h\u0131zl\u0131 geldi\u011fini kan\u0131tlad\u0131!<\/p>\n"},"faq":[{"question":"Rocket Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emri verin ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"Rocket Pharmaceuticals hisseleri riskli mi?","answer":"Evet, y\u00fcksek volatilite ve klinik deneme riskleri nedeniyle biyotek hisseleri genellikle y\u00fcksek risk ta\u015f\u0131r."},{"question":"FDA klinik durdurmas\u0131 nedir ve neden \u00f6nemlidir?","answer":"FDA klinik durdurmas\u0131, bir denemenin g\u00fcvenlik endi\u015feleri nedeniyle ge\u00e7ici olarak durdurulmas\u0131d\u0131r. Bu, hisse fiyatlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir."},{"question":"Rocket Pharmaceuticals'in gelecekteki fiyat beklentileri nelerdir?","answer":"Analistlere g\u00f6re 2025 sonunda 24-27 $, 2030'da ise 60-80 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir, ancak bu klinik ba\u015far\u0131 ve piyasa ko\u015fullar\u0131na ba\u011fl\u0131d\u0131r."},{"question":"Yeni ba\u015flayanlar i\u00e7in Rocket Pharmaceuticals hissesi yat\u0131r\u0131m\u0131 \u00f6nerileri nelerdir?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n, stop-loss kullan\u0131n ve klinik geli\u015fmeleri yak\u0131ndan takip edin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Rocket Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emri verin ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"Rocket Pharmaceuticals hisseleri riskli mi?","answer":"Evet, y\u00fcksek volatilite ve klinik deneme riskleri nedeniyle biyotek hisseleri genellikle y\u00fcksek risk ta\u015f\u0131r."},{"question":"FDA klinik durdurmas\u0131 nedir ve neden \u00f6nemlidir?","answer":"FDA klinik durdurmas\u0131, bir denemenin g\u00fcvenlik endi\u015feleri nedeniyle ge\u00e7ici olarak durdurulmas\u0131d\u0131r. Bu, hisse fiyatlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir."},{"question":"Rocket Pharmaceuticals'in gelecekteki fiyat beklentileri nelerdir?","answer":"Analistlere g\u00f6re 2025 sonunda 24-27 $, 2030'da ise 60-80 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir, ancak bu klinik ba\u015far\u0131 ve piyasa ko\u015fullar\u0131na ba\u011fl\u0131d\u0131r."},{"question":"Yeni ba\u015flayanlar i\u00e7in Rocket Pharmaceuticals hissesi yat\u0131r\u0131m\u0131 \u00f6nerileri nelerdir?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n, stop-loss kullan\u0131n ve klinik geli\u015fmeleri yak\u0131ndan takip edin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T20:44:55+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T20:44:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/\",\"name\":\"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-25T20:44:55+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T20:44:55+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T20:44:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/","name":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-25T20:44:55+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Rocket Pharmaceuticals, Inc. (RCKT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Rocket Pharmaceuticals, Inc. (RCKT) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":351326,"slug":"how-to-buy-rocket-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rocket Pharmaceuticals, Inc. (RCKT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rocket Pharmaceuticals, Inc. (RCKT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":351323,"slug":"how-to-buy-rocket-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Rocket Pharmaceuticals, Inc. (RCKT) - Investimento em a\u00e7\u00f5es da Rocket Pharmaceuticals, Inc. (RCKT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-rocket-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/351324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=351324"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/351324\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=351324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=351324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=351324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}